FMOPhore for hotspot identification and efficient fragment-to-lead growth strategies

P Peter E. G. F. Ibrahim S Simone Altmann U Ulrich Zachariae (Department of Computational Biology, School of Life Sciences, University of Dundee 5 , Dow Street, Dundee DD1 5EH,) D David Horn I Ian H. Gilbert (Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee) M Michael J. Bodkin

Abstract

Abstract Fragment based drug design is like a chess game in that a good or a bad move can dramatically influence the outcome. In the design process, it is important to identify the key binding site residues (hotspots) that can have a substantial impact on ligand potency and efficiency. Here, we introduce FMOPhore algorithm represented with a scoring function named FP-score, which combines Quantum Mechanics Fragment Molecular Orbital calculations with 3D-protein-ligand pharmacophore models. FP-score accurately classifies binding site residues in two classes: 1) Hotspot residues (Delineated into three categories; Anchor, Transient, and Accessible) and 2) non-hotspot residues. We apply our algorithm in two different scenarios: holo-complex and apo-structure, testing its robustness on 46 different protein targets including an experimental case study on drug-resistance hotspots across 829 protein-ligand complexes. We handle protein binding site flexibility using Dy-FMOPhore which improves the detection of hotspots. FMOPhore provides valuable insight for efficient, selective fragment growing and lead optimization strategies.

Article Details

Volume / Issue Vol. 17, Issue 1
Published April 28, 2026
ISSN 2041-1723
Publisher Nature Portfolio

Journal Info

Nature Communications

Nature Portfolio

ISSN: 2041-1723 Open Access Life Sciences

Authors (6)

P

Peter E. G. F. Ibrahim

S

Simone Altmann

U

Ulrich Zachariae

Department of Computational Biology, School of Life Sciences, University of Dundee 5 , Dow Street, Dundee DD1 5EH,

D

David Horn

I

Ian H. Gilbert

Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee

M

Michael J. Bodkin